Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2018

Sep 7, 2018

30786_dirs_2018-09-07_948a7477-bd76-4239-876b-aa7cfd073c67.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-RAD LABORATORIES, INC. (BIO, BIOB)
CIK: 0000012208
Period of Report: 2018-09-05

Reporting Person: HERTIA JOHN (Executive Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-09-05 Bio-Rad A Common Stock M 600 Acquired 13162 Direct
2018-09-05 Bio-Rad A Common Stock F 208 $315.50 Disposed 12954 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-09-05 Restricted Stock Units $0 M 600 Disposed Bio-Rad A Common Stock (600) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Bio-Rad A Common Stock 252 Indirect

Footnotes

F1: Shares of Class A common stock acquired on the vesting of restricted stock units.

F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F3: The restricted stock units vest in five equal annual installments beginning September 5, 2018.